Dr. Reddy's Laboratories announced the earnings call results for Q1 FY26 held on July 23, 2025, showing a profit after tax of 1,419 crores ($166 million), a YoY growth of 2% but a QoQ decline of 11%, with revenues increasing by 11%. The company reported a net cash surplus of 2,922 crores ($341 million) and advanced its business strategies, especially in biosimilars.